NeoGenesis Pharmaceuticals Announces Major Breakthrough in Drug Discovery Technology
New technique for affinity measurement in mixtures of chemical compounds allows researchers to optimize drug leads with increased speed and greater mechanistic insight
10-Nov-2004 -
Cambridge. NeoGenesis Pharmaceuticals, Inc. announced that they have demonstrated a new, powerful drug discovery technology for evaluating and optimizing the affinities of lead compounds for disease-associated protein targets.
In a study published in the Journal of the American ...
Binding Site
chemical biology
chemistry
+4